Latest stories on TELYF
TelyRx Announces Departure of Chief Revenue Officer
StockTitan42 · neutralgeneral
TelyRx appoints Benjamin Atkins as interim CEO
Seeking Alpha52 · neutralgeneral
TelyRx Appoints Co-Founder Benjamin Atkins as Interim Chief Executive Officer and President
StockTitan52 · neutralgeneral
TelyRx Holdings Inc. GAAP EPS of -$0.06
Seeking Alpha63 · neutralearnings
TelyRx Announces Board Changes
StockTitan50 · neutralgeneral
TelyRx Announces Third Quarter 2026 Financial Results
StockTitan50 · neutralearnings
TelyRx to Host Third Quarter 2026 Financial Results Conference Call on Friday, November 6, 2026 at 8:30 am ET
StockTitan50 · neutralgeneral
TelyRx Expands Women's Health Offerings with New Menopause Supplement
PR Newswire56 · neutralproduct/pr
TelyRx Holdings Inc. GAAP EPS of -$0.09, revenue of $22.7M misses by $8.81M
Seeking Alpha34 · bearishearnings
TelyRx Announces Second Quarter 2026 Financial Results
StockTitan56 · neutralearnings
TelyRx Launches New Brand and Digital Experience Inspired by Patient Feedback
PR Newswire56 · neutralproduct/pr
TelyRx Holdings Inc. Announces DTC Eligibility for U.S. Traded Shares | TELYF Stock News
StockTitan59 · neutralgeneral
TelyRx to Present at the Global Technology Virtual Investor Conference July 9th
Business Insider56 · neutralgeneral
TelyRx Announces Voting Results from Annual General Meeting of Shareholders | TELYF Stock News
StockTitan50 · neutralgeneral
TelyRx Surpasses 1 Million Prescriptions, Underscoring Growing Demand for Digital Pharmacy | TELYF Stock News
StockTitan67 · bullishproduct/pr
TelyRx Commences Trading on the OTCQX Market in the United States | TELYF Stock News
StockTitan50 · neutralgeneral